O-3 Efficacy and safety of entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis of three clinical trials (STARTRK-2, STARTRK-1 and ALKA-372-001)
暂无分享，去创建一个
A. Drilon | G. Demetri | R. Doebele | F. D. De Braud | F. Ciardiello | L. Bazhenova | C. Rolfo | S. Siena | S. Lonardi | D. Sigal | I. Garrido-Laguna | Y. Chae | P. Conkling | X. Huang | S. Osborne | K. Goto | S. Liu | F. Longo | M. Patel | A. Aziez